Total amount raised
$386.5 Millions
Latest funding date
Location
Cleerly has successfully raised funds through multiple rounds, with the latest being a Series C round closed on December 4, 2024. The company has attracted 20 investors, including notable names like Insight Partners and Battery Ventures.
Cleerly's platform leverages AI-driven analysis of 3D coronary computed tomography angiography (CCTA) imaging to provide precise and comprehensive heart health insights. Keep reading to explore the intricacies of Cleerly's fundraising journey and the investors backing this innovative platform.
What Is Cleerly?
Cleerly, founded in 2017 by James K. Min, is a digital healthcare company based in Denver, Colorado. The company operates within the healthcare, medical, and AI industries, focusing on heart disease diagnosis solutions.
With a team of 101-250 employees, Cleerly leverages advanced AI technology to analyze 3D coronary computed tomography angiography (CCTA) imaging. This approach provides precise and comprehensive heart health insights, aiming to prevent heart attacks and improve cardiovascular care.
How Much Funding Has Cleerly Raised?
- Series A
- Amount Raised: $14.5M
- Date: August 2017
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To establish the company and develop its initial AI-driven heart disease diagnosis solutions.
- Series B
- Amount Raised: $43M
- Date: June 2021
- Lead Investors: Vensana Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the company's AI technology and enhance its diagnostic capabilities.
- Series C
- Amount Raised: $223M
- Date: July 2022
- Lead Investors: Fidelity, T. Rowe Price
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the company's growth and development, including a large, multi-year clinical trial and efforts to gain regulatory clearance for widespread heart disease screening.
- Series C Extension
- Amount Raised: $106M
- Date: December 2024
- Lead Investors: Insight Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale Cleerly's commercial growth and generate clinical evidence, aiming to improve patient outcomes and eliminate heart attacks.
Total amount raised: $386.5M. Current valuation: Not publicly disclosed.
Key Investors
- Insight Partners
- Details: Insight Partners is a global venture capital and private equity firm investing in high-growth technology and software companies. The firm has over $80 billion in regulatory assets under management and has invested in more than 800 companies worldwide.
- Investment Focus Areas: Software, Internet, Data Services
- Notable Investments: Twitter, Shopify, DocuSign
- Fidelity
- Details: Fidelity Investments is one of the largest asset managers in the world, providing investment management, retirement planning, portfolio guidance, and brokerage services. The firm is known for its diverse investment portfolio and long-term client success.
- Investment Focus Areas: Financial Services, Technology, Healthcare
- Notable Investments: Uber, SpaceX, Airbnb
- T. Rowe Price
- Details: T. Rowe Price is a global investment management firm dedicated to helping clients achieve long-term success. The firm offers a broad range of investment services, including mutual funds, retirement plans, and institutional investments.
- Investment Focus Areas: Mutual Funds, Retirement Plans, Institutional Investments
- Notable Investments: Tesla, Amazon, Google
- Vensana Capital
- Details: Vensana Capital is a venture capital firm focused on investing in medical technology and healthcare companies. The firm aims to support innovative solutions that improve patient outcomes and advance medical care.
- Investment Focus Areas: Medical Technology, Healthcare
- Notable Investments: Inari Medical, Intact Vascular, Bolder Surgical
- Battery Ventures
- Details: Battery Ventures is a global, technology-focused investment firm that invests in companies at all stages of their growth. The firm is known for its commitment to supporting technological advancements and innovation.
- Investment Focus Areas: Technology, Software, Web Infrastructure
- Notable Investments: Glassdoor, Nutanix, Coupa
What's Next for Cleerly?
Cleerly stands at the cusp of a transformative journey, with opportunities to scale its commercial growth and generate clinical evidence. The company aims to make advanced cardiac care accessible to more patients, leveraging AI-driven analysis for early detection and prevention of coronary artery disease. The cardiovascular disease market, costing $422 billion annually in the U.S., presents a significant opportunity for Cleerly to expand its reach and impact.
Future fundraising opportunities appear promising, given the strong investor interest demonstrated in the recent $106 million Series C extension round. The involvement of major investors like Insight Partners suggests potential for additional funding rounds to support further growth and innovation. However, Cleerly will need to navigate regulatory hurdles and prove the efficacy of its technology through ongoing clinical trials to ensure widespread adoption and integration into healthcare systems.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Cleerly and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
